Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 61, Issue SUPPL. 2, 2002, Pages

  Strand, V ^a   Landewe R ^b   Van der Heijde, D ^b  

^a STANFORD UNIVERSITY   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTHRITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HAND RADIOGRAPHY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0036839020     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Sharp JT, Lidsky MD, Collins LS, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706-20.
2. Sharp JT. Scoring radiographic abnormalities in rheumatoid arthritis. Radiol Clin North Am 1966;34:233.
3. van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression of radiographs of the hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995;22:1792-6.
4. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with reflunomide compared with placebo and methotrexate. Arch Intern Med 1999;159:2542-50.
5. Smolen JS, Kalden JR, Scott DL, Bozman B, Kvien TK, Larsen A, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial Lancet 1999;353:259-66.
6. Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gomor B, et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000;39:655-65.
7. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 2000;43:495-505.
8. Scott DL, Smolen JS, Kalden JR, van de Putte LBA, Larsen A, Kvien TK, et al. Treatment of active rheumatoid arthritis with leflunomide: Two year follow up of a double blind placebo controlled trial versus sulfasalazine. Ann Rheum Dis 2001;60:913-23.
9. Lipsky PE, van der Heijde DMFM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
10. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
11. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljian Z, Emery P, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998;41:2196-204.
12. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000;43:1001-9.
13. Genovese M, Bathon J, Martin R, Fleischmann R, Tesser JR, Schiff MH, et al. Etanercept vs methotrexate in patients with early rheumatoid arthritis (ERA trial): Two year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443-50.
14. Sharp JT, Wolfe F, Corbett M, Isomaki H, Mitchell DM, Furst DE, et al. Radiological progression in rheumatoid arthritis: How many patients are required in a treatment trial to test disease modification? Ann Rheum Dis 1993;52:332-7.
15. Strand V, Sharp JT. Radiographic data from recent RCTs in RA: what have we learned? Arthritis Rheum (in press).
16. Wolfe F, Strand V. Radiography of rheumatoid arthritis in the time of increasing drug effectiveness. Curr Rheumatol Rep 2001;3:46-52.
17. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999;26:743-5.
18. Strand V, Lassere M, van der Heijde D, Johnson K, Boers M. Recent rheumatoid arthritis clinical trials using radiographic endpoints - Updated research agenda. J Rheumatol 2001;28:887-9.
19. Boers M. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the ACR 20% criteria: The paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Arthritis Rheum 2001;44:2703-4.
20. Keystone E, Han C, Keenan GF, van der Heijde D, Harriman G. Infliximab plus methotrexate prevents structural damage progression in rheumatoid arthritis patients independent of clinical response [abstract]. Arthritis Rheum 2001;44:S81.
21. Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000;39:122-32.
22. Landewe RB, van der Heijde D, Verhoven A, Boonen A, Boers M, van der Linden S. Radiological progression rate at baseline predicts treatment differences: Results from the COBRA trial [abstract]. Arthritis Rheum 2001;44:S371.
23. van der Heijde D, Landewe RB, Lipsky PE, Maini RN. Radiological progression rate at baseline predicts treatment differences: Results from the ATTRACT trial [abstract]. Arthritis Rheum 2001;44:S80.
24. Cohen S, Cannon G, Schiff M, Weaver A, Fox R, Olsen N, et al for ULTRA trial investigators group, Strand V. Two year treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum 2001;44:1984-92.